[3H]5'-N-ethylcarboxamide Adenosine Binds to Both Ra and Ri Adenosine Receptors in Rat Striatum

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1984 Mar 1

PMID 6328332

Citations 22

Authors

S M Yeung

R D Green

Affiliations

Soon will be listed here.

Abstract

Adenosine analogs such as 5'-N- ethylcarboxamide adenosine and N6-cyclohexyladenosine stimulate or inhibit adenosine cyclase activity in preparations of rat striatum depending on the assay conditions. N6-cyclohexyladenosine inhibits but does not stimulate adenosine cyclase activity in preparations of hippocampus. These findings suggest that the striatum contains both Ra (stimulatory) and Ri (inhibitory) adenosine receptors while the hippocampus contains only Ri receptors. We have previously shown that [3H]N6-cyclohexyladenosine binds to Ri receptors in rat hippocampus ( Yeung and Green 1983). Comparisons of the characteristics of [3H]5'-N- ethylcarboxamide adenosine and [3H]N6-cyclohexyladenosine binding to hippocampus show that [3H]5'-N- ethylcarboxamide adenosine also binds to Ri receptors with high affinity. [3H]5'-N- ethylcarboxamide adenosine binds to Ri receptors in the striatum and to a second site that is present in striatum but not hippocampus. High affinity binding of both ligands to Ri receptors can be blocked by treatments with N-ethylmaleimide that do not markedly affect [3H]5'-N- ethylcarboxamide adenosine binding to the second site in the striatum. The pharmacological characteristics of the second site indicate that it is the Ra adenosine receptor.

Citing Articles

Adenosine A(2A) Receptor Antagonists and Parkinson's Disease.

Shook B, Jackson P ACS Chem Neurosci. 2012; 2(10):555-67.

PMID: 22860156 PMC: 3369712. DOI: 10.1021/cn2000537.

A(2A) adenosine receptors in human peripheral blood cells.

Gessi S, Varani K, Merighi S, Ongini E, Borea P Br J Pharmacol. 2000; 129(1):2-11.

PMID: 10694196 PMC: 1621134. DOI: 10.1038/sj.bjp.0703045.

Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding.

Varani K, Gessi S, Dalpiaz A, Borea P Br J Pharmacol. 1996; 117(8):1693-701.

PMID: 8732278 PMC: 1909568. DOI: 10.1111/j.1476-5381.1996.tb15341.x.

Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Zocchi C, Ongini E, Ferrara S, Baraldi P, Dionisotti S Br J Pharmacol. 1996; 117(7):1381-6.

PMID: 8730729 PMC: 1909468. DOI: 10.1111/j.1476-5381.1996.tb15296.x.

Endogenous adenosine as a modulator of hippocampal acetylcholine release.

Jackisch R, Strittmatter H, Kasakov L, Hertting G Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(4):319-25.

PMID: 6083455 DOI: 10.1007/BF00506243.

References

Jones D, Matus A . Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim Biophys Acta. 1974; 356(3):276-87. DOI: 10.1016/0005-2736(74)90268-5. View

Murray T, Cheney D . Neuronal location of N6-cyclohexyl[3H]adenosine binding sites in rat and guinea-pig brain. Neuropharmacology. 1982; 21(6):575-80. DOI: 10.1016/0028-3908(82)90050-8. View

Yeung S, Green R . Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide. J Biol Chem. 1983; 258(4):2334-9. View

Stadel J, Lefkowitz R . Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupled beta-adrenergic receptors. Mol Pharmacol. 1979; 16(3):709-18. View

Trost T, Schwabe U . Adenosine receptors in fat cells. Identification by (-)-N6-[3H]phenylisopropyladenosine binding. Mol Pharmacol. 1981; 19(2):228-35. View

Premont J, Perez M, Blanc G, Tassin J, Thierry A, Herve D . Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution. Mol Pharmacol. 1979; 16(3):790-804. View

Schwabe U, Trost T . Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine. Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(3):179-87. DOI: 10.1007/BF00505731. View

Cooper D . Bimodal regulation of adenylate cyclase. FEBS Lett. 1982; 138(2):157-63. DOI: 10.1016/0014-5793(82)80431-6. View

Londos C, Cooper D, Wolff J . Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980; 77(5):2551-4. PMC: 349439. DOI: 10.1073/pnas.77.5.2551. View

10.

Bruns R . Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol. 1980; 58(6):673-91. DOI: 10.1139/y80-110. View

11.

Londos C, Cooper D, Schlegel W, Rodbell M . Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci U S A. 1978; 75(11):5362-6. PMC: 392963. DOI: 10.1073/pnas.75.11.5362. View

12.

Cooper D, Londos C . Evaluation of the effects of adenosine on hepatic and adipocyte adenylate cyclase under conditions where adenosine is not generated endogenously. J Cyclic Nucleotide Res. 1979; 5(4):289-302. View

13.

Kilpatrick B, De Lean A, Caron M . Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides. Mol Pharmacol. 1982; 22(2):298-303. View

14.

Munson P, Rodbard D . Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980; 107(1):220-39. DOI: 10.1016/0003-2697(80)90515-1. View

15.

Williams M, RISLEY E . Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]adenosine, a stable analog of adenosine. Proc Natl Acad Sci U S A. 1980; 77(11):6892-6. PMC: 350397. DOI: 10.1073/pnas.77.11.6892. View

16.

Schutz W, TUISL E, KRAUPP O . Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn Schmiedebergs Arch Pharmacol. 1982; 319(1):34-9. DOI: 10.1007/BF00491475. View

17.

Anand-Srivastava M, Johnson R . Regulation of adenosine-sensitive adenylate cyclase from rat brain striatum. J Neurochem. 1980; 35(4):905-14. DOI: 10.1111/j.1471-4159.1980.tb07089.x. View

18.

Harden T, Scheer A, Smith M . Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s). Mol Pharmacol. 1982; 21(3):570-80. View

19.

Jakobs K, Lasch P, Minuth M, Aktories K, Schultz G . Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide. J Biol Chem. 1982; 257(6):2829-33. View

20.

Londos C, Wolff J . Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A. 1977; 74(12):5482-6. PMC: 431772. DOI: 10.1073/pnas.74.12.5482. View